tirzepatide surpass SURPASS-CVOT trial: For patients with high-risk type 2 diabetes, the effect of tirzepatide, a dual agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide receptors, on cardiovascular outcomes is uncertain. Research is summarized Cardiovascular outcomes of semaglutide and

Understanding the distinction between true oedema and other phenomena is essential for appropriate management of your diabetes care

EarthChimp mixes smoothly and is easy to sip, which makes it practical when chewing feels like too much or meals feel unappealing

What to record: Number of bathroom visits per day (daytime and nighttime separately) Approximate volume (small, moderate, large) Any pain, burning, urgency, or incontinence Urine color throughout the day Total daily fluid intake (type and amount) Current tirzepatide dose and how long at this dose All other medications and supplements Blood sugar readings if applicable This data allows your provider to quickly distinguish between harmless metabolic adjustment and something requiring investigation

However, Schumer said she was having a really good experience with Mounjaro, such as improved menopause symptoms and libido

Mussa, Hala Zakaria Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef Assessment of basic pharmacokinetic parameters of dapagliflozin in TTS formulations in male minipigs Biernat Pawe, Radosaw Balwierz, Dyliski Mieszko, Koacki Mikoaj, Ewa Micewicz, Bursy Dawid, ukasz Pogorzelec Scientific Reports.2024;[Epub] CrossRef Crosstalk of Hyperglycaemia and Cellular Mechanisms in the Pathogenesis of Diabetic Kidney Disease Esienanwan Esien Efiong, Homa Bazireh, Markta Fuchs, Peter Uchenna Amadi, Emmanuel Effa, Sapna Sharma, Christoph Schmaderer International Journal of Molecular Sciences.2024

If you have a significant amount of weight to lose, some procedures and medications can help you lose weight and keep it off, but there are benefits and drawbacks to consider with each